| Year |
Citation |
Score |
| 2020 |
Santiago F, Doscher E, Kim J, Camps M, Meza J, Sindi S, Barlow M. Growth rate assays reveal fitness consequences of β-lactamases. Plos One. 15: e0228240. PMID 32004340 DOI: 10.1371/Journal.Pone.0228240 |
0.377 |
|
| 2017 |
Mira P, Barlow M, Meza JC, Hall BG. Statistical Package for Growth Rates Made Easy. Molecular Biology and Evolution. PMID 29029174 DOI: 10.1093/Molbev/Msx255 |
0.521 |
|
| 2016 |
Seigal A, Mira P, Sturmfels B, Barlow M. Does Antibiotic Resistance Evolve in Hospitals? Bulletin of Mathematical Biology. PMID 27924410 DOI: 10.1007/S11538-016-0232-7 |
0.336 |
|
| 2015 |
Mira PM, Meza JC, Nandipati A, Barlow M. Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change. Molecular Biology and Evolution. 32: 2707-15. PMID 26113371 DOI: 10.1093/Molbev/Msv146 |
0.369 |
|
| 2015 |
Mira PM, Crona K, Greene D, Meza JC, Sturmfels B, Barlow M. Rational design of antibiotic treatment plans: a treatment strategy for managing evolution and reversing resistance. Plos One. 10: e0122283. PMID 25946134 DOI: 10.1371/Journal.Pone.0122283 |
0.363 |
|
| 2014 |
Hall BG, Acar H, Nandipati A, Barlow M. Growth rates made easy. Molecular Biology and Evolution. 31: 232-8. PMID 24170494 DOI: 10.1093/Molbev/Mst187 |
0.518 |
|
| 2013 |
Hall BG, Cardenas H, Barlow M. Using complete genome comparisons to identify sequences whose presence accurately predicts clinically important phenotypes. Plos One. 8: e68901. PMID 23935901 DOI: 10.1371/Journal.Pone.0068901 |
0.558 |
|
| 2013 |
Hall BG, Kirkup BC, Riley MC, Barlow M. Clustering acinetobacter strains by optical mapping. Genome Biology and Evolution. 5: 1176-84. PMID 23739739 DOI: 10.1093/Gbe/Evt085 |
0.512 |
|
| 2013 |
Goulart CP, Mahmudi M, Crona KA, Jacobs SD, Kallmann M, Hall BG, Greene DC, Barlow M. Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes. Plos One. 8: e56040. PMID 23418506 DOI: 10.1371/Journal.Pone.0056040 |
0.603 |
|
| 2012 |
McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW, Zurawski DV. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. Journal of Microbiology (Seoul, Korea). 50: 434-43. PMID 22752907 DOI: 10.1007/S12275-012-1555-1 |
0.348 |
|
| 2011 |
de Vries LE, Vallès Y, Agersø Y, Vaishampayan PA, García-Montaner A, Kuehl JV, Christensen H, Barlow M, Francino MP. The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. Plos One. 6: e21644. PMID 21738748 DOI: 10.1371/Journal.Pone.0021644 |
0.334 |
|
| 2010 |
Salverda ML, De Visser JA, Barlow M. Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. Fems Microbiology Reviews. 34: 1015-36. PMID 20412308 DOI: 10.1111/J.1574-6976.2010.00222.X |
0.405 |
|
| 2009 |
Barlow M. What antimicrobial resistance has taught us about horizontal gene transfer. Methods in Molecular Biology (Clifton, N.J.). 532: 397-411. PMID 19271198 DOI: 10.1007/978-1-60327-853-9_23 |
0.424 |
|
| 2009 |
Barlow M, Fatollahi J, Salverda M. Evidence for recombination among the alleles encoding TEM and SHV beta-lactamases. The Journal of Antimicrobial Chemotherapy. 63: 256-9. PMID 19010826 DOI: 10.1093/Jac/Dkn475 |
0.408 |
|
| 2008 |
Baquirin MH, Barlow M. Evolution and recombination of the plasmidic qnr alleles. Journal of Molecular Evolution. 67: 103-10. PMID 18592295 DOI: 10.1007/S00239-008-9131-3 |
0.343 |
|
| 2008 |
Mroczkowska JE, Barlow M. Fitness trade-offs in blaTEM evolution. Antimicrobial Agents and Chemotherapy. 52: 2340-5. PMID 18443128 DOI: 10.1128/Aac.00018-08 |
0.404 |
|
| 2008 |
Barlow M, Reik RA, Jacobs SD, Medina M, Meyer MP, McGowan JE, Tenover FC. High rate of mobilization for blaCTX-Ms. Emerging Infectious Diseases. 14: 423-8. PMID 18325257 DOI: 10.3201/Eid1403.070405 |
0.365 |
|
| 2008 |
Hall BG, Barlow M. Barlow-Hall in vitro Evolution Protocol Nature Precedings. 3: 1-1. DOI: 10.1038/Npre.2008.1772.1 |
0.533 |
|
| 2006 |
Rao AN, Barlow M, Clark LA, Boring JR, Tenover FC, McGowan JE. Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerging Infectious Diseases. 12: 1011-4. PMID 16707065 DOI: 10.3201/Eid1206.051596 |
0.368 |
|
| 2006 |
Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, Klugman KP. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrobial Agents and Chemotherapy. 50: 943-8. PMID 16495255 DOI: 10.1128/Aac.50.3.943-948.2006 |
0.377 |
|
| 2006 |
Hall BG, Barlow M. Phylogenetic analysis as a tool in molecular epidemiology of infectious diseases. Annals of Epidemiology. 16: 157-69. PMID 16099674 DOI: 10.1016/J.Annepidem.2005.04.010 |
0.54 |
|
| 2005 |
Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Thomson JM, Anderson VE, Barlow M, Rice LB, Tenover FC, Bonomo RA. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrobial Agents and Chemotherapy. 49: 2941-8. PMID 15980372 DOI: 10.1128/Aac.49.7.2941-2948.2005 |
0.473 |
|
| 2005 |
Hall BG, Barlow M. Revised Ambler classification of {beta}-lactamases. The Journal of Antimicrobial Chemotherapy. 55: 1050-1. PMID 15872044 DOI: 10.1093/Jac/Dki130 |
0.544 |
|
| 2005 |
Welsh KJ, Barlow M, Tenover FC, Biddle JW, Rasheed JK, Clark LA, McGowan JE. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrobial Agents and Chemotherapy. 49: 1242-4. PMID 15728940 DOI: 10.1128/Aac.49.3.1242-1244.2005 |
0.413 |
|
| 2004 |
Hall BG, Salipante SJ, Barlow M. Independent origins of subgroup B1 + B2 and subgroup B3 metallo-β-lactamases Journal of Molecular Evolution. 59: 133-141. PMID 15383916 DOI: 10.1007/S00239-003-2572-9 |
0.578 |
|
| 2004 |
Hall BG, Barlow M. Evolution of the serine beta-lactamases: past, present and future. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 7: 111-23. PMID 15158767 DOI: 10.1016/J.Drup.2004.02.003 |
0.623 |
|
| 2003 |
Salipante SJ, Barlow M, Hall BG. GeneHunter, a Transposon Tool for Identification and Isolation of Cryptic Antibiotic Resistance Genes Antimicrobial Agents and Chemotherapy. 47: 3840-3845. PMID 14638492 DOI: 10.1128/Aac.47.12.3840-3845.2003 |
0.62 |
|
| 2003 |
Hall BG, Barlow M. Structure-based phylogenies of the serine beta-lactamases. Journal of Molecular Evolution. 57: 255-60. PMID 14629035 DOI: 10.1007/S00239-003-2473-Y |
0.604 |
|
| 2003 |
Hall BG, Salipante SJ, Barlow M. The metallo-β-lactamases fall into two distinct phylogenetic groups Journal of Molecular Evolution. 57: 249-254. PMID 14629034 DOI: 10.1007/S00239-003-2471-0 |
0.6 |
|
| 2003 |
Barlow M, Hall BG. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC beta-lactamase. Genetics. 164: 23-9. PMID 12750318 |
0.623 |
|
| 2003 |
Barlow M, Hall BG. Experimental prediction of the natural evolution of antibiotic resistance. Genetics. 163: 1237-41. PMID 12702671 |
0.609 |
|
| 2002 |
Barlow M, Hall BG. Phylogenetic analysis shows that the OXA beta-lactamase genes have been on plasmids for millions of years. Journal of Molecular Evolution. 55: 314-21. PMID 12187384 DOI: 10.1007/S00239-002-2328-Y |
0.633 |
|
| 2002 |
Barlow M, Hall BG. Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii. Antimicrobial Agents and Chemotherapy. 46: 1190-8. PMID 11959544 DOI: 10.1128/Aac.46.5.1190-1198.2002 |
0.651 |
|
| 2002 |
Barlow M, Hall BG. Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase. Genetics. 160: 823-32. PMID 11901104 |
0.594 |
|
| Show low-probability matches. |